000			02037 a2200589 4500
005			20250517174721.0
264		0	_c20180529
008			201805s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdx340 _2doi
040			_aNLM _beng _cNLM
100	1		_aTakamatsu, H
245	0	0	_aPrognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cOct 2017
300			_a2503-2510 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents, Alkylating _xtherapeutic use
650	0	4	_aBone Marrow Transplantation _xmethods
650	0	4	_aDisease-Free Survival
650	0	4	_aHigh-Throughput Nucleotide Sequencing _xmethods
650	0	4	_aHumans
650	0	4	_aMelphalan _xtherapeutic use
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNeoplasm, Residual _xgenetics
650	0	4	_aPolymerase Chain Reaction _xmethods
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aStem Cell Transplantation _xmethods
650	0	4	_aTransplantation, Autologous
650	0	4	_aTreatment Outcome
700	1		_aTakezako, N
700	1		_aZheng, J
700	1		_aMoorhead, M
700	1		_aCarlton, V E H
700	1		_aKong, K A
700	1		_aMurata, R
700	1		_aIto, S
700	1		_aMiyamoto, T
700	1		_aYokoyama, K
700	1		_aMatsue, K
700	1		_aSato, T
700	1		_aKurokawa, T
700	1		_aYagi, H
700	1		_aTerasaki, Y
700	1		_aOhata, K
700	1		_aMatsumoto, M
700	1		_aYoshida, T
700	1		_aFaham, M
700	1		_aNakao, S
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 10 _gp. 2503-2510
856	4	0	_uhttps://doi.org/10.1093/annonc/mdx340 _zAvailable from publisher's website
999			_c27600034 _d27600034